WallStreetZenWallStreetZen

NASDAQ: KLRS
Kalaris Therapeutics Inc Stock Ownership - Who owns Kalaris Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Kalaris Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Brett R. HagenChief Accounting Officer2025-03-26907$8.97
$8.13kSell
Edward MillerGeneral Counsel2025-02-21106$10.08
$1.07kSell
Brett R. HagenChief Accounting Officer2025-02-2196$10.08
$967.30Sell
Vikas SinhaOfficer Title President Chief Financial Officer and Chief Executive Officer2025-02-21303$10.08
$3.05kSell
Edward MillerGeneral Counsel2025-01-2347$9.45
$444.34Sell
Edward MillerGeneral Counsel2025-01-235$9.94
$49.70Sell
Vikas SinhaOfficer Title President Chief Financial Officer and Chief Executive Officer2025-01-2313$9.94
$129.22Sell
Brett R. HagenChief Accounting Officer2025-01-2332$9.45
$302.53Sell
Brett R. HagenChief Accounting Officer2025-01-234$9.94
$39.76Sell
Vikas SinhaOfficer Title President Chief Financial Officer and Chief Executive Officer2025-01-23116$9.45
$1.10kSell

1 of 3

KLRS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KLRS insiders and whales buy or sell their stock.

KLRS Shareholders

What type of owners hold Kalaris Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Morana Jovanembiricos425.09%79,502,507$380.82MInsider
David Hallal372.69%69,701,844$333.87MInsider
Vikas Sinha182.46%34,123,650$163.45MInsider
Ansbert Gadicke161.08%30,125,933$144.30MInsider
Elevatebio LLC89.16%16,674,766$79.87MInsider
Gilead Sciences Inc88.95%16,635,286$79.68MInsider
Samsara Biocapital GP LLC61.21%11,448,081$54.84MInsider
Samsara Biocapital LLC61.21%11,448,081$54.84MInstitution
F2 Mg Ltd52.55%9,828,091$47.08MInsider
John Robert Wilson46.67%8,727,908$41.81MInsider

1 of 3

KLRS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KLRS4.47%95.53%Net Selling
STTK59.88%31.06%Net BuyingNet Buying
EQ14.64%24.17%Net Selling
STRO65.81%18.36%Net SellingNet Buying
PTHS2.57%97.43%Net Buying
View Top Biotech Stocks

Kalaris Therapeutics Stock Ownership FAQ

Who owns Kalaris Therapeutics?

Kalaris Therapeutics (NASDAQ: KLRS) is owned by 71.45% institutional shareholders, 1,528.64% Kalaris Therapeutics insiders, and 0.00% retail investors. Morana Jovanembiricos is the largest individual Kalaris Therapeutics shareholder, owning 79.50M shares representing 425.09% of the company. Morana Jovanembiricos's Kalaris Therapeutics shares are currently valued at $368.10M.

If you're new to stock investing, here's how to buy Kalaris Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.